Incyte (INCY) Construction in Progress (2019 - 2022)
Incyte (INCY) reported Construction in Progress of $176.2 million for Q4 2022, down 10.74% on a YoY basis from $197.4 million in Q4 2021, and down 10.74% quarter-over-quarter from $197.4 million in Q4 2021.
Incyte (INCY) Construction in Progress (2019 - 2022) Analysis & Trends
Incyte has reported Construction in Progress for 4 years, with the latest figure at $176.2 million in Q4 2022.
- For the quarter ending Q4 2022, Construction in Progress fell 10.74% year-over-year to $176.2 million; the trailing twelve-month figure through Dec 2022 stood at $176.2 million (down 10.74% YoY), and the FY2022 full-year result was $176.2 million, down 10.74% from the prior year.
- Construction in Progress for Q4 2022 stood at $176.2 million, down from $197.4 million in the prior quarter.
- The five-year high for Construction in Progress was $197.4 million in Q4 2021, with the low at $2.0 million in Q1 2019.
- Historically, Construction in Progress has averaged $63.4 million across 4 years, with a median of $20.8 million in 2020.
- Annual changes were most pronounced in 2021 — Construction in Progress surged 1002.79% — and 2022, when it fell 10.74%.
- Incyte's Construction in Progress stood at $13.8 million in 2019, then gained by 29.71% to $17.9 million in 2020, then surged by 1002.79% to $197.4 million in 2021, then slipped by 10.74% to $176.2 million in 2022.
- The last three Construction in Progress figures came in at $176.2 million (Q4 2022), $197.4 million (Q4 2021), and $140.7 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 176.20 Mn |
| Dec 31, 2021 | 197.40 Mn |
| Sep 30, 2021 | 140.70 Mn |
| Jun 30, 2021 | 125.60 Mn |
| Mar 31, 2021 | 19.10 Mn |
| Dec 31, 2020 | 17.90 Mn |
| Sep 30, 2020 | 23.80 Mn |
| Jun 30, 2020 | 22.40 Mn |
| Mar 31, 2020 | 18.20 Mn |
| Dec 31, 2019 | 13.80 Mn |
| Jun 30, 2019 | 3.90 Mn |
| Mar 31, 2019 | 2.00 Mn |